abstract |
The present invention relates generally to methods and materials for use in the treatment or prevention of diseases (eg, cognitive impairment) using diaminophenothiazine. In particular, the present invention relates to treatments with optimized pharmacokinetic properties, and the dosage form is intended to improve the relative cognition of this diaminophenothiazine or CNS benefits, eg, compared to hematological effects. Has been. [Selection figure] None |